In a filing, Korro Bio Inc revealed its Chief Financial Officer Agarwal Vineet unloaded Company’s shares for reported $56000.0 on Nov 11 ’24. In the deal valued at $70.00 per share,800 shares were sold. As a result of this transaction, Agarwal Vineet now holds 0 shares worth roughly $0.0.
Then, Agarwal Vineet bought 800 shares, generating $56,000 in total proceeds.
Before that, Agarwal Vineet sold 10,216 shares. Korro Bio Inc shares valued at $799,527 were divested by the Chief Financial Officer at a price of $78.26 per share. As a result of the transaction, Agarwal Vineet now holds 0 shares, worth roughly $0.0.
Oppenheimer initiated its Korro Bio Inc [KRRO] rating to an Outperform in a research note published on January 10, 2025; the price target was $155. A number of analysts have revised their coverage, including Raymond James’s analysts, who began to cover the stock in late October with a ‘”a Strong buy”‘ rating. William Blair began covering KRRO with “an Outperform” recommendation on August 14, 2024. H.C. Wainwright maintained its rating on March 28, 2024. It rated KRRO as “a Buy”.
Price Performance Review of KRRO
On Friday, Korro Bio Inc [NASDAQ:KRRO] saw its stock jump 0.05% to $37.00. Over the last five days, the stock has gained 4.93%. Korro Bio Inc shares have fallen nearly -2.81% since the year began. Nevertheless, the stocks have fallen -15.20% over the past one year. While a 52-week high of $98.00 was reached on 01/02/25, a 52-week low of $30.00 was recorded on 01/10/25. SMA at 50 days reached $47.39, while 200 days put it at $48.57.
Levels Of Support And Resistance For KRRO Stock
The 24-hour chart illustrates a support level at 36.15, which if violated will result in even more drops to 35.30. On the upside, there is a resistance level at 38.10. A further resistance level may holdings at 39.20. The Relative Strength Index (RSI) on the 14-day chart is 39.90, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.40, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 65.76%. Stochastics %K at 34.24% indicates the stock is a holding.
How much short interest is there in Korro Bio Inc?
A steep rise in short interest was recorded in Korro Bio Inc stocks on 2024-12-31, growing by 0.35 million shares to a total of 0.65 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-29 was 0.3 million shares. There was a rise of 54.11%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on February 27, 2024 when BMO Capital Markets began covering the stock and recommended ‘”an Outperform”‘ rating along with a $120 price target.
